CYSTIC FIBROSIS (CF)

Drug development companies are regularly contacting us to take part in new clinical trials for improved CF treatments, and we are keen to do so, as this provides Western Australians with CF the opportunity to access new treatments.

If you suffer from CF and would like to be considered for enrolment for participation in a clinical trials, please contact us by telephoning 9346 4964, email This e-mail address is being protected from spambots. You need JavaScript enabled to view it or click here to register online.

Study outline	Recruitment status
VX09-809-102: A 3 month study to learn about the safety and efficacy of one study medication alone and in combination with another on patients with the delta 508 gene mutation. Both study medications are tablets that are taken daily. The study comprises of 9 visits over approx 3 months. This is an international study.	Recruiting soon!
VX09-770-102: A study to Evaluate the Efficacy and Safety of VX-770 drug in Subjects with Cystic Fibrosis and the G551D Mutation.	Recruiting closed
VX09-770-105 An Open-Label, Rollover Study to Evaluate the Long-Term Safety and Efficacy of VX-770 in Subjects With Cystic Fibrosis.	Recruiting closed